» Articles » PMID: 12432908

Phospholipase A2 Enzymes

Overview
Date 2002 Nov 16
PMID 12432908
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid (AA), a precursor of eicosanoids including prostaglandins and leukotrienes. The same reaction also produces lysophosholipids, which represent another class of lipid mediators. So far, at least 19 enzymes that possess PLA2 activity have been identified and cloned in mammals. The secretory PLA2 (sPLA2) family, in which 10 isozymes have been identified, consists of low-molecular weight, Ca2+-requiring secretory enzymes that have been implicated in a number of biological processes, such as modification of eicosanoid generation, inflammation, and host defense. The cytosolic PLA2 (cPLA2) family consists of three enzymes, among which cPLA2alpha has been paid much attention by researchers as an essential component of the initiation of AA metabolism. The activation of cPLA2alpha is tightly regulated by Ca2+ and phosphorylation. The Ca2+-independent PLA2 (iPLA2) family contains two enzymes and may play a major role in phospholipid remodeling. The platelet-activating factor (PAF) acetylhydrolase (PAF-AH) family contains four enzymes that exhibit unique substrate specificity toward PAF and/or oxidized phospholipids. Degradation of these bioactive phospholipids by PAF-AHs may lead to the termination of inflammatory reaction and atherosclerosis.

Citing Articles

Low-dose Bee Venom as a Potential Therapeutic Agent Against Human Chronic Myeloid Leukaemia Cells.

Halici H, Un H, Celik S, Karakoy Z, Bayraktutan Z, Ozlu C Protein J. 2025; .

PMID: 39924635 DOI: 10.1007/s10930-025-10251-2.


Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.

He S, Xu Z, Han X Mol Neurodegener. 2025; 20(1):11.

PMID: 39871348 PMC: 11773937. DOI: 10.1186/s13024-025-00803-6.


Effect of Statin Treatment on Lipoprotein-Associated Phospholipase A2 Mass and Activity: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.

Sahebkar A, Reiner Z, Almahmeed W, Jamialahmadi T, Simental-Mendia L Cardiovasc Drugs Ther. 2024; .

PMID: 39466484 DOI: 10.1007/s10557-024-07634-5.


Genome-wide discovery and integrative genomic characterization of insulin resistance loci using serum triglycerides to HDL-cholesterol ratio as a proxy.

DeForest N, Wang Y, Zhu Z, Dron J, Koesterer R, Natarajan P Nat Commun. 2024; 15(1):8068.

PMID: 39277575 PMC: 11401929. DOI: 10.1038/s41467-024-52105-y.


Glycerophospholipid dysregulation after traumatic brain injury.

Sarkar C, Lipinski M Neurochem Int. 2024; 175:105701.

PMID: 38428503 PMC: 11040658. DOI: 10.1016/j.neuint.2024.105701.